EHD4 Antibodies

Santa Cruz Biotechnology delivers a wide array of EHD4 monoclonal antibodies for research focused on understanding EHD4's role in cellular processes. The monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). EHD4, or EH domain-containing protein 4, is crucial for endocytic recycling and membrane trafficking, playing a significant role in maintaining cellular homeostasis. The involvement of EHD4 in the regulation of clathrin-mediated endocytosis highlights its importance in various physiological processes, including cell signaling and nutrient uptake. Research has shown that EHD4 expression levels can influence cellular function and development. Understanding EHD4's molecular mechanisms can provide valuable insights into normal cellular processes and disease states. Dysregulation of EHD4 has been linked to several pathological conditions, highlighting its significance in human health. Current research continues to uncover new functions and regulatory mechanisms of EHD4 in different cellular contexts. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance their understanding of EHD4's role in biological processes and disease mechanisms.